What has creationism ever done for us?

[MagusYanam]

My question is simply this: in light of the fact that Darwin's model of biological evolution has contributed vastly to our understanding of genetics and has advanced beyond question the fields of agriculture, medicine, environmental ecology, palaeontology and thus geology, what has the creation model done to further man's more noble pursuits? Exactly what purpose is it serving? In other words, where is the utility in creationism and how is it supposed to better our lot in the universe?

[ENIGMA]

I seriously question your declaration that Darwin's model of biological evolution has contributed vastly to our understanding of genetics etc...

Isn't that a bit harsh? Darwin identified a general principle operating in nature that he could see would be capable of producing self-organized "design". The search for the actual mechanism in biological systems was only completed much later, however it still had Darwin's original template to match. Obviously for the sake of argument it is not necessary for findings in genetics to match this template, but while they continue to do so we have a compelling reason to believe that biology gets it's "design" from natural logic.

No!

Yes!

Maybe!

Only on Thursdays!

[jcrawford]

Darwin identified a general principle operating in nature that he could see would be capable of producing self-organized "design".

The concept and recognition of "design" is common to both creationism and Darwinism. In Darwinism though, the concept of "design" is limited in application to recognizing and differentiating between those biological organisms whose homologies are similar in structure and function, and are subsequently organized into nested hierarchies on the basis of their common design.

The search for the actual mechanism in biological systems was only completed much later, however it still had Darwin's original template to match. Obviously for the sake of argument it is not necessary for findings in genetics to match this template, but while they continue to do so we have a compelling reason to believe that biology gets it's "design" from natural logic.

Whether the use of logic is a "natural" or supernatural faculty of humans is a topic worthy of discussion and debate in itself. As far as this post is concerned though, the existance and reality of such abstract ideas and concepts as "common" and "design" themselves may be said to be more supernatural than "natural," for purposes of scientific or philosophical investigation.
Obviously, I may be classified as one who believes that without certain fundamental philosophical insights into the "nature" and origins of the human mind, neither science nor religion may be properly understood or applied.

[QED]

I seriously question your declaration that Darwin's model of biological evolution has contributed vastly to our understanding of genetics etc...

Isn't that a bit harsh? Darwin identified a general principle operating in nature that he could see would be capable of producing self-organized "design". The search for the actual mechanism in biological systems was only completed much later, however it still had Darwin's original template to match. Obviously for the sake of argument it is not necessary for findings in genetics to match this template, but while they continue to do so we have a compelling reason to believe that biology gets it's "design" from natural logic.

No!

According to the debating rules:

5. Support your assertions/arguments with evidence. Do not make blanket statements that are not supportable by logic/evidence.

9. No unconstructive one-liners posts are allowed in debates (Do not simply say "Ditto" or "I disagree" in a post. Such posts add little value to debates).

If you have an argument to offer against the post of mine you quoted here please present it. Without such support "No" looks very much like "I simply can't accept that, but I can't think of a good reason know why".

[Bart007]

I seriously question your declaration that Darwin's model of biological evolution has contributed vastly to our understanding of genetics etc...

Isn't that a bit harsh? Darwin identified a general principle operating in nature that he could see would be capable of producing self-organized "design". The search for the actual mechanism in biological systems was only completed much later, however it still had Darwin's original template to match. Obviously for the sake of argument it is not necessary for findings in genetics to match this template, but while they continue to do so we have a compelling reason to believe that biology gets it's "design" from natural logic.

No!

According to the debating rules:

5. Support your assertions/arguments with evidence. Do not make blanket statements that are not supportable by logic/evidence.

9. No unconstructive one-liners posts are allowed in debates (Do not simply say "Ditto" or "I disagree" in a post. Such posts add little value to debates).

If you have an argument to offer against the post of mine you quoted here please present it. Without such support "No" looks very much like "I simply can't accept that, but I can't think of a good reason know why".

I rarely write one word ansers or one liners. I thought some here might appreciate that

I wrote a post just prior to saying "NO!" where your question is answered in some detail. Perhaps you skipped over it.

Blythe and Mendel, especially Mendel, are responsoble for unlocking the modern science of genetics. It is a very great wrong to assign the honor to Darwin that belongs to Mendel. Mendel got it right, Darwin was clueless and only had Hippocrates theory of Pangenesis as his mode for variation. Darwin stole the conceot of Natural Selection from creationists from William Paley and Edward Blyth.

Natural Selection can not be THE cause for evolution or even A cause for evolution because it is incapable of producing novel changes in the genome. If evolution should some day be scientifically demonstrated to be true, then Only mutation to the genetic code can be the cause of it.

Natural selection does fit very well with the creationists use of the term, it selects from a huge amount of characteristics that are coded in the chromosomes to enable living creatures to adapt to different environments and changing ecologies, so as to enable the 'type' to survive.; and it tends to eliminates genetic mistakes to help keep the 'type' genetically fit. As such, it is a conserving force that preserve the species type, as Paley and Blyth claimed; not a novel force for producing new characteristics as Darwin had thought.

Gregor Mendel. a Christian and a creationists, is the Father of Genetics, lets give credit to whom credit is due.

[Grumpy]

Bart007

Natural Selection can not be THE cause for evolution or even A cause for evolution because it is incapable of producing novel changes in the genome. If evolution should some day be scientifically demonstrated to be true, then Only mutation to the genetic code can be the cause of it.

It might interest you to know that Mutation of the genetic code with natural selection IS evolution and it has been shown to be valid and to bring novel changes to the genome(google the nylon bug, hint, nylon has only existed since the 30's). It has thus been scientificly shown to be true.

Try to keep up, OK???

Grumpy 8)

[Chimp]

EDIT--Sorry, Grumpy beat me to this...was slow in posting...not trying to gang
up on anyone :/

Natural Selection can not be THE cause for evolution or even A cause for evolution because it is incapable of producing novel changes in the genome. If evolution should some day be scientifically demonstrated to be true, then Only mutation to the genetic code can be the cause of it.

Natural selection is a mechanism akin to a force acting on a population. It
does not, in and of itself, produce anything.

Changes in the alleles themselves comes about through mutation, recombination
and horizontal transfer. Natural selection affects the propagation of the
mutations, but as stated earlier, does not cause the mutation.

But we digress.

Bart has made a number of excellent points about the contribution of
creationism to science, and I think to some degree answered the historical
question. More recently, I don't think creationism has faired so well.

[Bart007]

Bart007

Natural Selection can not be THE cause for evolution or even A cause for evolution because it is incapable of producing novel changes in the genome. If evolution should some day be scientifically demonstrated to be true, then Only mutation to the genetic code can be the cause of it.

It might interest you to know that Mutation of the genetic code with natural selection IS evolution and it has been shown to be valid and to bring novel changes to the genome(google the nylon bug, hint, nylon has only existed since the 30's). It has thus been scientificly shown to be true.

Try to keep up, OK???

Grumpy 8)

Hey grump, I will concede that if a mutation, or series of mutations produce a beneficial effect in a popuation, that natural selection may select it when it's beneficial use be required to contribute for survival. Mutations remain the only means for novel change.

I will show later that though certain point mutations have produced some benefits to some species, that mutation can not account for large scale evolution. But this is for another day. Someone asked me about the fossil record and I will go there next. Its' a good place to start.

In the mean time: Three cheers for Mendel, the Father of the science of genetics.

[Sender]

bart check your inbox and get back to me, thanks.

[Bart007]

EDIT--Sorry, Grumpy beat me to this...was slow in posting...not trying to gang
up on anyone :/

Natural Selection can not be THE cause for evolution or even A cause for evolution because it is incapable of producing novel changes in the genome. If evolution should some day be scientifically demonstrated to be true, then Only mutation to the genetic code can be the cause of it.

Natural selection is a mechanism akin to a force acting on a population. It
does not, in and of itself, produce anything.

Changes in the alleles themselves comes about through mutation, recombination
and horizontal transfer. Natural selection affects the propagation of the
mutations, but as stated earlier, does not cause the mutation.

But we digress.

Bart has made a number of excellent points about the contribution of
creationism to science, and I think to some degree answered the historical
question. More recently, I don't think creationism has faired so well.

Recombination and horizontal transfer is not novel channge, it is merely borrowing existing information from elsewhere. The Theory of Evolution must stand or fall on it's ability to produce novel alleles being introduced on a continuing basis and spreading through the population.

As for scientists who are creationists, they are very productive in their contributions to science. It is important to realize that most science does not deal with origins, most of it is operational science.

Here is a list of some of the published scientific papers produced by todays creationary scientists (the list is a few years old and is not meant to be exhaustive or complete):

Loren D. Haarsma Ph.D.
2. "Anti-hydrogen production with cold trapped plasmas" Phys Lett A129, 38 (1988) co-authored with G. Gabrielse, S. L. Rolston, and W. Kells
3. "Electrical Resistivity and Thermopower of the Liquid Alloy MgZn" J. Phys: Condens. Matter 1, 2923 (1989) co-authored with M. Walhout and J. B. Van Zytveld
4. "Open-endcap Penning Traps for High Precision Experiments" Int. J. of Mass Spectrom and Ion Proc. 88, 319 (1989) co-authored with G. Gabrielse and S. L. Rolston
7. "A Single Trapped Antiproton and Antiprotons for Antihydrogen Production" Hyperfine Interactions 81, 5 (1993) co-authored with G. Gabrielse, W. Jhe, D. Phillips, W. Quint, K. Abdullah, H. Kalinowsky, and J. Grobner
8. "Extremely Cold Positrons for Antihydrogen Production" Hyperfine Interactions 76, 143 (1993) co-authored with G. Gabrielse and K. Abdullah
9. "Extremely Cold Antiprotons for Antihydrogen Production" Hyperfine Interactions 76, 81 (1993) co-authored with G. Gabrielse, W. Jhe, D. Phillips, W. Quint, C. Tseng, K. Abdullah, J. Grobner and H. Kalinowsky
10. "Extremely cold positrons accumulated electronically in ultra-high vacuum" Phys. Rev. Lett. 75, 806 (1995)
Donald Hamann Ph.D. ( - May 12, 1996)
1. "Effects of grind size, sucrose concentration and salt concentration on peanut butter texture" Journal of Texture Studies 20(1): 29-41 (1989) co-authored with K. L. Crippen and C. T. Young
2. "Influence of poultry species, muscle groups, and nacl level on strength, deformability, and water retention in heat-set muscle gels" Journal of Food Science 54(5): 1136+ (September - October, 1989) co-authored with P. M. Amato, H. R. Ball, and E. A. Foegeding
3. "Inhibition of morodi (gel weakening) in surimi by plasma hydrolysate and egg white" Journal of Food Science 55(3): 665+ (May - June, 1990) co-authored with P. M. Amato, M. C. Wu, and E. A. Foegeding
4. "Myosin gelation kinetic study based on rheological measurements" Journal of Agricultural and Food Chemistry 39(2): 229-236 (February, 1991) co-authored with J. Q. Wu
5. "Effect of starch gelatinization on physical properties of extruded wheat-based and corn-based products" Cereal Chemistry 69(4): 401-404 (July - August, 1992) co-authored with S. E. Case, S. J. Schwartz, and E. A. Foegeding
Terrence John Hamblin MB, ChB, DM, FRCP, FRCPath (March 12, 1943 - )
38. "The problems of anticoagulant control. I Drug interactions" Bristol Medico-Chirurgical Journal 85(316): 101-104 (October, 1970)
39. "Problems of anticoagulant control. II Which test?" Bristol Medico-Chirurgical Journal 86:71-74 (1971)
40. "The effect of an intravenous histidine load on the plasma levels of other amino acids" Clin Chim Acta 42:37-41 (1972) co-authored with JB Holton
41. "Mononucleosis and the miniskirt: an incompatible combination" British Medical Journal 4:708-709 (1972)
42. "Leucocyte alloantigens in the kidney. II A quantitative approach" Transplantation 14:29-34 (1972) co-authored with J Verrier Jones, Gwendoline Margree and Barbara Moore
43. "Adult acute leukaemia - a suitable case for treatment?" Bristol Medico-Chirurgical Journal 88:11-15 (1973) co-authored with J Verrier Jones
44. "Distinctive cytoplasmic inclusions in chronic lymphatic leukaemia" European Journal of Cancer 11:91-92 (1975) JC Cawley, J Emmines, AH Goldstone, DW Hough and JL Smith
45. "The immune response to ox 174 in man: iv primary and secondary antibody production in patients with chronic lymphatic leukaemia" Clinical and Experimental Immunology 21:101-108 (1975) co-authored with J Verrier Jones and DB Peacock
46. "Plasmapheresis in the treatment of acute systematic lupus erythematosus" Lancet i: 709-711 (1976) co-authored with J Verrier Jones, RC Bucknall, RH Cumming, CM Asplin, ID FRaser, Joy Bothamley, and P Davis
47. "IgA and IgM cytoplasmic inclusions in a series of cases of chronic lymphocytic leukaemia" Clinical and Experimental Immunology 23:78-80 (1976)
48. "Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes" Journal of Experimental Medicine 144:960-969 (1976) co-authored with DW Hough, RP Eady, FK Stevenson and GT Stevenson
49. "Chronic lymphatic leukaemia: correlation of immunofluorescent characteristics and clinical features" British Journal of Haematology 36:359-365 (1977) co-authored with DW Hough
50. "Heterocellular hereditary persistence of fetal haemoglobin (heterocellular HPFH) and its interaction with B thalassaemia" British Journal of Haematology 36:461-473 (1977) co-authored WG Wood, DG Weatherall, JB Clegg, JH Edmonds, and AM Barlow
51. "Polyarteritis nodosa presenting with thrombocytosis and palliated by plasmapheresis" Postgraduate Medical Journal 54:615-617 (1978) co-authored with DG Oscier
52. "Antibodies to keratin in rheumatoid arthritis" British Medical Journal 2:98-99 (1979) co-authored with B. Young, R. Mallya, D Leslie and CJ Clark
53. "A possible role for plasmapheresis in the management of Crohn's disease" Digestion 19:197-201 (1979) co-authored with G Holdstock, A Fisher and CA Loehry
54. "Acute systemic lupus erythematosus: a therapeutic role for plasmapheresis" Plasma Therapy 1:33-42 (1979) co-authored with J Verrier Jones, ID Fraser, Joy Bothamley and P Davis
55. "Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surface" British Journal of Cancer, 42:495-502 (1980) co-authored with AK Abdul-Ahad, J Gordon, FK Stevenson and GT Stevenson
56. "Extracellular idiotypic immunoglobulin arising from human leukaemic B lymphocytes" Journal of Experimental Medicine 152: 1484-1496 (1980) co-authored with FK Stevenson, GT Stevenson and AC Tutt
57. "Concident chronic lymphocytic leukaemia and osteocsclerotic multiple myeloma" Blood 57:617-619 (1981) co-authored with T Jeha and JL Smith
58. "The oldest case of carcoidosis in the world" British Medical Journal 283:190 (1981) co-authored with I Brown and J Mikhail
59. "Toxic confusional state and choreiform movement after treatment with anabolic steroids" British Medical Journal 283:349-350 (1981) co-authored with A Tilsey and J Heptonstall
60. "The effect of plasma exchange on the in vitro monocyte function of patients with immune complex diseases" Clinical and Experimental Immunology 45:240-245 (1981) co-authored with MM Steven, AR Tanner, GE Holdstock, R Cockerell, J Smith, DS Smith, and R Wright
61. "A human B-cell lymphoma synthesizing and expressing surface u-chain in the absence of detectable light chain" Blood 58:522-556 (1981) co-authored with J Gordon, JL Smith, FK Stevenson and GT STevenson
62. "Plasma exchange and a placebo procedure in auto erythrocyte sensitisation" British Medical Journal 283:1575-1576 (1981) co-authored with S Hart and GJ Mufti
63. "Severe deafness in SLE: its immediate relief by plasma exchange" British Medical Journal 182:1374 (1982) co-authored with GJ Mufti and A Bracewell
64. "Basic isoferritin and hypercalcaemia in a patient with hypernephroma" Journal of Clinical Pathology 35:1008-1010 (1982) co-authored with GJ Mufti and J Stevens
65. "Polycythaemia rubra vera and hairy cell leukaemia in the same patient" studies on the spleen"Journal of Clinical Pathology 35: 1312-1315 (1982) co-authored with GJ Mufti, M Fitchett and FK Stevenson
66. "Delayed haemolytic transfusion reaction caused by anti Fyb in a splenectomised patient" Transfusion 22:402 (1982) co-authored with IP Boyland and GJ Mufti
67. "Acute transformation of a myeloproliferative state in sideroblastic anaemia with abnormal karyotype" Journal of Cytogenetics 19: 478 (1982) co-authored with GJ Mufti and M Seabright
68. "Long term plasma exchange in SLE: a feasible treatment" Journal of Clinical and Laboratory Research 13:95-102 (1983) co-authored with DS Smith
69. "Melphalan induced pulmonary fibrosis in a case of osteosclerotic myeloma" Acta Haematologica 69:140-141 (1983) co-authored with GJ Mufti and J Gordon
70. "The aplasia leukaemia syndrome. Aplastic anaemia followed by dyserythropoiesis, then by a myeloproliferative syndrome and its transformation into acute myeloid leukaemia" Acta Haematologica 69:349-352 (1983) co-authored with GJ Mufti and J Lee-Potter
71. "Anti keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease" Clinical and Experimental Immunology 51:17-20 (1983) co-authored with RK Mallya, BJ Young, MB Pepys, BEW Mace and END Hamilton
72. "Coexistent myelodysplasia and plasma cell neoplasia" British Journal of Haematology 54:91-96 (1983) co-authored with GJ Mufti, C Race and GP Clein
73. "Exercise induced angio-oedema: its relief with Intal" Postgraduate Medical Journal 59:43-44 (1983) co-authored with S Hatty and GJ Mufti
74. "Plasma exchange in Sjogrens syndrome and polymyositis" Plasma Therapy 4:185-188 (1983) co-authored with CJ Clark
75. "A case of drug resistance pre B ALL with an 8:14 and 14:18 chromosomal rearrangement" Blood 62:1142-1146 (1983) co-authored with GJ Mufti, DG Oscier and C Johnson
76. "Plasma exchange in rhesus haemolytic disease: the danger of aminocentesis" International Journal of Artificial Organs 6:83-85 (1983) co-authored with C Grant, DS Smith and L Wellstead
77. "Complications of constructing arteriovenous grafts and fistulae for plasma exchange" Apheresis Bulletin 1:92-95 (1983) co-authored with AJ Bell and GJ Mufti
78. "Immunological reason for ill health after infectious monocleosis" British Medical Journal 287:85-88 (1983) co-authored with J Hussein, A Akbar, YC Tang, JL Smith and D Jones
79. "Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukaemia" New England Journal of Medicine 309:1653-1654 (1983) co-authored with GJ Mufti, DG Oscier and AJ Bell
80. "Relapse of lymphoma in the heart after a 10 year remission" Postgraduate Medical Journal 60:607-610 (1984) co-authored with AJ Bell and GJ Mufti
81. "Angiodysplasia on the colon: a source of chronic blood loss in patients with a pre-existing bleeding diathesis" Angiology (1984): 511-514 co-authored with AJ Bell, GJ Mufti and DG Oscier
82. "Polymyalgia rheumatica and antimitochondrial antibodies" Annals of Rheumatic Disease 43:264-266 (1984) co-authored with MA Sattar, MID Cawley and JC Robertson
83. "Factor X deficiency associated with primary amyloidosis" Apheresis Bulletin 3:60-63 (1984) co-authored with JA Copplestone, RJ van de Star and DM Chisholm
84. "Plasma exchange in a patient with irreversible splenic atrophy" Apheresis Bulletin 2(2):39-42 (1984) co-authored with GJ Mufti and N Kent
85. "Circulating antigen" a barrier to successful serotherapy that may be evaded by plasmapheresis" Apheresis Bulletin 2(2): 17-34 (1984) co-authored with J Gordon, FK Stevenson and GT Stevenson
86. "Barriers to successful immunotherapy with anti-idiotype antibody" British Journal of Cancer49: 547-557 (1984) co-authored with J Gordon, A Abdul-Ahad, FK Stevenson and GT Stevenson
87. "Serious effusions in monocytic leukaemia" British Journal of Haematology 58:547-552 (1984) co-authored with GJ Mufti, DG Oscier, A Nightingale and S Darlow
88. "The effect of a single plasmapheresis on the immune response to phi-x 174: comparison of primary and secondary response" Apheresis Bulletin 2(3):32-37 (1984) co-authored with D Johnstone
89. "Myelodysplastic syndromes: a scoring system with prognostic importance" British Journal of Haematology 59:425-433 (1985) co-authored with GJ Mufti, J Stevens and DG Oscier
90. "Hairy cell leukaemia and Legionnaire's disease" British Journal of Diseases of the Chest 79:198-200 (1985) co-authored with V Chowdhury, DG Oscier and GJ Mufti
91. "Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosis" Acta Haematologica 411:37-39 (1985) co-authored with S Hatty and GJ Mufti
92. "Successful treatment of post transfusion purpura with high dose intravenous immunoglobulin after lack of response to plasma exchange" Vox Sang 48:164-167 (1985) co-authored with S Naorose Abidi, PA Nee, A Copplestone, GJ Mufti and DG Oscier
93. "Reciprocal translocation between chromosomes 8 and 9 in atypical chronic myeloid leukaemia" Journal of Medical Genetics 22: 398-401 (1985) co-authored with DG Oscier, GJ Mufti and A Gardiner
94. "Primary myelodysplastic syndrome with a complex karyotypic abnormality in a patient with Kleinfelters syndrome" Journal of Medical Genetics 23:183-195 (1986) co-authored with GJ Mufti, DG Oscier and M Fitchett
95. "Immunological abnormalities in myelodysplasia: I. Serum immunoglobulins and auto antibodies" British Journal of Haematology 63:143-14 (1986) co-authored with GJ Mufti, A Figes, DG Oscier and JA Copplestone
96. "Immunological abnormalities in myelodysplasia: II. Co-existent lymphoid or plasma cell neoplasms. A report of 20 cases unrelated to chemotherapy" British Journal of Haematology 63:149-159 (1986) co-authored with JA Copplestone, GJ Mufti and
DG Oscier
97. "Terminal deoxynucleotidyl transferase positive transformation of a chronic post-thymic T cell malignancy" Scandinavian Journal of Hematology 36:221-228 (1986) co-authored with DG Oscier, GJ Mufti, DB Jones and JL Smith
98. "Analysis of soluble HLA Class I antigenic material in patients with immunological disease using monoclonal antibodies" Journal of Immunological Methods 86:187-190 (1986) co-authored with FK Stevenson, AJT George and MT Walters
99. "Skin infiltration in chronic myelomonocytic leukaemia" Clinical and Laboratory Haematology 8:115-119 (1986) co-authored with JA Copplestone, DG Oscier and GJ Mufti
100. "Autoimmunity in chronic lymphocytic leukaemia" Journal of Clinical Pathology 39:713-716 (1986) co-authored with DG Oscier and BJ Young
101. "Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumours" Blood 69:430-436 (1986) co-authored with FK Stevenson, M Wrightham, MJ Glennie, DB Jones, AR Cattan, T Feizi and GT Stevenson
102. "Initial experience in treating human lymphoma with a chimaeric univalent derivative of monoclonal anti-idiotype antibody" Blood 69:790-797 (1987) co-authored with AR Cattan, MJ Glennie, MR MacKenzie, HF Watts and GT Stevenson
103. "Monoclonal anti-light chain idiotype as a tumour specific probe for human neoplastic B lymphocytes" Blood 69:919-923 (1987) co-authored with M Wrightham, AL Tutt, MJ Glennie, GT Stevenson and FK Stevenson
104. "Long survival in B CLL correlates with IgM K phenotype" British Journal of Haematology 66:21-26 (1987) co-authored with DG Oscier, JR Stevens and JL Smith
105. "Peripheral blood stem cells as a source of autograft in lymphoid malignancies" British Journal of Haematology 66:63-68 (1987) co-authored with AJ Bell, A Figes and DG Oscier
106. "Monoclonal antibodies: in vivo or in vitro" Plasma Therapy 7:437-442 (1987)
107. "Reduced survival of isotope-labelled Rh(d)-negative donor red cells in a patient with anti-LWab" Vox Sanguinis 51:314-317 (1987) co-authored with R Herron, AJ Bell, J Poole, M Clark and DS Smith
108. "Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinations" Leukemia Research 11:971-978 (1987) co-authored with GE Francis, GJ Mufti, SM Knowles, JJ Berney, JET Guimaraes and LM Secker-Walker
109. "Generation of lymphokine activated killer cells in a totally closed system" Plasma Therapy and Transfusion Technology 8: 271-176 (1987) co-authored with AJ Bell, M Wrightham and FK Stevenson
110. "Prognostic features of chronic myelomoncytic leukaemia: a modified Bournemouth score gives the best prediction of survival" British Journal of Haematology 68:17-21 (1988) co-authored with AM Worsley, DG Oscier, J Stevens, S Darlow, A Figes and GJ Mufti
111. "Circulating stem cell autografts in the treatment of haematological malignancies" Plasma Theory 9:133-138 (1988) co-authored with AJ Bell, P Reynolds, A Figes and DG Oscier
112. "Heterogeneity in neoplastic cell populations in chronic lymphocytic leukaemia defined by immunoglobulin expression and secretion in vitro" Leukemia Research 12:123-128 (1988) co-authored with E Gregg, J Smith and FK Stevenson
113. "CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia" Journal of Clinical Pathology 41:746-752 (1988) co-authored with JL Smith, DG Oscier, D Haegart, DB Jones, WM Howell, E Hodges and FK Stevenson
114. "Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human FC" Blood 72:1985-1991 (1988) co-authored with RJ Dearman, FK Stevenson, M Wrightham, MJ Glennie and GT Stevenson
115. "Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia" Leukemia Research 11:805-810 (1988) co-authored with J Gow, D Hughes, C Farr, DG Oscier, R Brown and RA Padua
116. "Idiotypic vaccination as a treatment for a B cell lymphoma" Journal of Immunology 141:2168-2174 (1988) co-authored with AJT George, SG Folkard and FK Stevenson
117. "Modification of monoclonal antibodies for immunotherapy" Plasma Theory and Transfustion Technology 10:27-39 (1989)
118. "Treatment of acute leukaemia in the elderly" Haematological Oncology 7:53-59 (1989) co-authored with JA Copplestone, AG Smith, C Osmond and DG Oscier
119. "Identification of normal B cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity" British Journal of Haematology 72:9-18 (1989) co-authored with FK Stevenson, GJ Smith, J North and MJ Glennie
120. "A phase II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma" Cancer Treatment Reviews 16:163-167 (1989) co-authored with V Inzani, S Sadullah, FK Stevenson, PJ Williamson, J Van der Plas,
P Palmer and CR Franks
121. "Treatment of chronic myelomoncytic leukaemia with low dose etoposide" British Journal of Haematology 72:468-471 (1989) co-authored with DG Oscier, A Worsley and GJ Mufti
122. "Pyogenic abscesses in the myelodysplastic syndrome" British Medical Journal 299:375-376 (1989) co-authored with PJ Williamson, DG Oscier and GJ Mufti
123. "Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score" Leukemia Research 13:833-839 (1989) DG Oscier, A Worsley, S Darlow, A Figes and JD Williams
124. "Prognostic features of early chronic lymphocytic leukaemia" Lancet 2:968-9 (1989) co-authored with J-L Binet, D Catovsky, C Chastang, G Dighero, J Fooks, D Galton, A Gates, and twelve others
125. "Prognostic factors in stage AO B cell chronic lymphocytic leukaemia" British Journal of Haematology 76:348-351 (1990) co-authored with DG Oscier, J Stevens and M Fitchett
126. "Prognostic significance of chromosomal abnormalities in B cell chronic lymphocytic leukaemia" British Journal of Haematology 76:352-8 (1990) co-authored with DG Oscier, J Stevens, R Lambert, M Fitchett
127. "Peripheral blood stem cell autografts in myeloma" Bone Marrow Transplantation 5: suppl 1:52-4 (1990) co-authored with AJ Bell, J North and FK Stevenson
128. "Isolation and EBV transformation of a minor population of normal human tonsillar B cells bearing a cold agglutinin associated idiotype" Journal of Autoimmunity 3:759-771 (1990) co-authored with G. Smith, M Spellerberg, J North and FK Stevenson
129. "LAK cells and Interleukin-2" Transfusion Science 12:35-42 (1991)
130. "Pure red cell aplasia in myelodysplastic syndrome" Journal of Clinical Pathology 44:431-2 (1991) co-authored with PJ Williamson, DG Oscier and AJ Bell
131. "Idiotypic vaccination against B-cell lymphoma leads to dormant tumour" Cellular Immunology 132:70-83 (1991) co-authored with RJ Dyke, H McBride, AJT George and FK Stevenson
132. "Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody" Blood 77:1071-9 (1991) co-authored with FK Stevenson, AJ Bell, R Cusack, CJ Slade, MB Spellerberg and GT Stevenson
133. "Nuceotide sequence analysis of the variable region genes encoding two IgM cold agglutinins: evidence that the VH4-21gene segment is responsible for the major crosss reactive idiotype" Journal of Immunology 146:4385-4391 (1991) co-authored with V Pasquale, K Victor, D Lelsz, MB Spellerberg, KM Thompson, I Randen, J Natvig, D Capra and FK Stevenson
134. "Clinical features of the Myelodysplastic Syndrome" Leukemia Research 16:89-93 (1992)
135. "The treatment of Acute Myeloid leukemia preceded by the myelodysplastic syndrome" Leukemia Research 16:101-108 (1992)
136. "VH restriction among human cold agglutinins: The VH4-21 gene segment is required to encode anti-I and anti-i specificities" Journal of Immunology 149:2337-2334 (1992) co-authored with V Pascual, K Victor, M Spellerberg, FK Stevenson and JD Capra
137. "Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilise the VH4-21 gene segment" Journal of Immunology 151:1051-1061 (1993) co-authored with CJ Chapman, MB Spellerberg, GA Smith, SJ Carter and FK Stevenson
138. "A Phase II study of Interleukin-2 and 5 Fluorouracil in metastatic colorectal cancer" British Journal of Cancer 68:1186-9 (1993) co-authored with S Sadullah, PJ Williamson, J Stevenson, R Oskam, P Palmer and CR Franks
139. "Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome" Leukemia 7:1891-5 (1993) co-authored with A Kruger, S Sadullah, R Chapman, E Hodges, S Mould and DG Oscier
140. "Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with SLE" Journal of Autoimmunity 6:809-825 (1993) co-authored with FK Stevenson, C Longhurst, CJ Chapman, M Ehrenstein, MB Spellerberg, C Ravirajan and D Isenberg
141. "Differential usage of an immunoglobulin heavy chain variable region gene by B-cell tumours" Blood 82:224-230 (1993) co-authored with FK Stevenson, MB Spellerberg, J Treasure, CJ Chapman, LE Silberstein and DJ Jones
142. "Recent advances in the management of myelodysplastic syndromes" Hematological Oncology 11(suppl 1) 27-31 (1993)
143. "Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells" Cellular Immunology 147:411-424 (1993) co-authored with CA King, MR Wills and FK Stevenson
144. "Genetic approach to idiotypic vaccination" Journal of Immunotherapy 14:273-8 (1993) co-authored with R. Hawkins, G Winter, FK Stevenson and SJ Russell
145. "Mechanisms of removal of tumour by antibody" Cell Biophysics 24:45-50 (1994) co-authored with GT Stevenson, AJ Bell, TRJ Evans, RR French, MJ Glennie, KS Kan and GM Mead
146. "Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single chain Fv "personal" vaccines" Blood 83:3279-88 (1994) co-authored with RE Hawkins,D Zhu, M Ovecka, G Winter, A Long and FK Stevenson
147. "Clonal history of follicular lymphoma as revealed in the immunoglobulin variable region genes" British Journal of Haematology 86:505-512 (1994) co-authored with D Zhu, RE Hawkins, and FK Stevenson
148. "Assessment of the role of clonogenic B-lymphocytes in the pathogenesis of multiple myeloma" Leukaemia 8:1285-9 (1994) co-authored with S Sahota, D Oscier and F Stevenson
149. "Long term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation and adjuvant radiotherapy" Cancer 73:1-4 (1994) co-authored with M McCullen, SK Vyas, PJ
Windwood, CA Loehry and D Parham
150. "Establishing the incidence of myelodysplastic syndromes" British Journal of Haematology 87:743-5 (1994) co-authored with PJ Williamson, A Kruger, PJ Reynolds and DG Oscier
151. "Differential usage of an autoantibody-associated VH gene VH4-21 by human B-cell tumours" Leukemia Lymphoma 16:379-84 (1995) co-authored with FK Stevenson, MB Spellerberg and CJ Chapman
152. "Treatment of B-cell lymphoma with a combination of bispecific antibodies and saporin" Lancet 1:223-4 (1995) co-authored with RR French, AJ Bell, A Tutt and MJ Glennie
153. "Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching" Molecular Immunology 32:347-353 (1995) co-authored with CJ Chapman, MB Spellerberg and FK Stevenson
154. "Chronic lymphocytic leukaemia - new drugs and management" J Royal Coll Physicians 29:419-421 (1995)
155. "Fludarabine related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia" British Journal ofHaematology 91:341-4 (1995) co-authored with H Myint, JA Copplestone, J Orchard, V Craig, D Curtis, AG Prentice, MD Hamon and DG Oscier
156. "Immunoglobulin VH gene mutational patterns indicate different tumor cell status in human myeloma and MGUS" Blood 87: 746-755 (1996) co-authored with SS Sahota, R Leo, and FK Stevenson
157. "Response of B cell lymphoma to treatment with bispecific antibodies and saporin" Leuk Res 20:607-617 (1996) co-authored with RR French, AJ Bell, A Tutt and MJ Glennie
158. "Blast transformation in chronic granulocytic leukaemia accompanied by the acquistion of inversion 16" Leuk Res 21:473-4 (1997) co-authored with H Myint and F Ross
159. "Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients" Brit J Haem 92:382-8 (1996) co-authored with E Matutes, D Oscier, J Garcia-Marco, J Ellis, A Copplestone,
R Gillingham, D Lens, GJ Swansbury and D Catovsky
160. "Prognostic factors in stage A chronic lymphocytic leukaemia: the importance of atypical lymphocyte morphology and ab- normal kayrotype for disease progression in stage A CLL" Brit J Haem 98:934-9 (1997) co-authored with DG Oscier, E
Matutes, A Copplestone, RM Pickering, R Chapman, G Gillingham and D Catovsky
161. "Use of a phage expression system to produce Fabs from human autoanti-DNA antibodies encoded by the VH4-21 gene seg-ment" Ann NY Acad Sci 764:576-9 (1995) co-authored with CJ Chapman, CI Mockridge, MB Spellerberg, MB Isenberg and
FK Stevenson
162. "Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene. A possible link between infection and lupus" Ann NY Acad Sci 764:427-432 (1995) co-authored with MB Spellerberg, C Chapman and F Stevenson
163. "Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching" Ann NY Acad Sci 764:195-7 (1995) co-authored with C Chapman, M Spellerberg and F Stevenson
164. "Tracking of the V4-34 (VH4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hyper-mutation" Clin Exper Immunol 105:360-8 (1996) co-authored with CJ Chapman, CI Mockridge and FK
Stevenson
165. "International scoring system for evaluating prognosis in myelodysplastic syndromes" Blood 89:2079-99 (1997) co-authored with P Greenberg, C Cox, M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, D Oscier, K Ohyashiki, K Toyarna,
C Aul, G Mufti and J Bennett
166. "Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumour cells" Blood 89: 219-226 (1997) co-authored with S Sahota, R Leo and FK Stevenson
167. "Cytokines to reduce platelet transfusions: non-TPO cytokines" Transfusion Science 18:121-128 (1997)
168. "Multiple myeloma associated with pure red cell aplasia which persisted despite the most intense immuno-modulation" Leuk Res 21:353-4 (1997) co-authored with JA Orchard and H Myint
169. "DNA vaccination as cancer immunotherapy" Biochemical Society Transactions 25:743-7 (1997) co-authored with D Zhu, MB
Spellerberg, A Thompsett, CA King and FK Stevenson
170. "DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C" J Immunol 159:1885-92 (1997) co-authored with MB Spellerberg, D Zhu, A Thompsett, CA
King and FK Stevenson
171. "A pilot of idiotypic vaccination for follicular B-cell lymphoma using a genetic approach. CRC NO: 92/33. Protocol NO: PH1/027" Human Gene Therapy 8:1287-99 (1997) co-authored with RE Hawkins, SJ Russell and F Stevenson
172. "Clinicians overview of platelet support" Transfusion Science 18:351-4 (1997)
173. "Complications in the treatment of CLL with purine analogues" Hematology and Cell Theory 39:(Suppl 1):S41-S44 (1997) co-authored with J Juliusson, J Seymor and S O'Brien
174. "DNA vaccines with single chain Fv fused fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma" Nature Medicine 4:1281-6 (1998) co-authored with CA King, MB Spellerberg, D Zhu, J Rice, SS Sahota, AR Thomsett, J Radl and FK Stevenson
175. "Unmutated immunoglobulin VH genes are associated with a more aggressive form of chronic lymphocytic leukemia" Blood 94: 1848-54 (1999) co-authored with Z Davis, A Gardiner, DG Oscier and FK Stevenson
176. "Relapsing polychondritis, smouldering non-secretory myeloma, and early myelodysplastic syndrome and in the same patient: three difficult diagnoses produce a life threatening illness" Leuk Res 24:91-3 (2000) co-authored with R Hall and N Hopkinson
177. "Antigen imprints myeloma tumor cells in VL and VH genes" Cancer Research Therapy and Clinical (2000) co-authored with SS Sahota, R Leo and FK Stevenson
178. "Immunoglobulin V genes and CD38 expression in CLL" Blood 95:2455-2457 (2000) co-authored with J Orchard, Z Davis, A Gardiner, DG Oscier and FK Stevenson
179. "Somatic mutation of bcl-6 genes can occur in the absence of V (H) mutations in chronic lymphocytic leukemia" Blood 95:3534-40 (2000) co-authored with SS Sahota, Z Davis and FK Stevenson
180. "CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease" Blood 99:1023-1029 (2002) co-authored with
JA Orchard, RE lbbotson, Z Davies, PW Thomas, FK Stevenson and DG Oscier
181. "Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma" Blood 99:2562-2568 (2002) co-authored with D Zhu, H McCarthy, CH Ottensmeier, P Johnson and
FK Stevenson
182. "Multivariate analysis of prognostic factors in CLL: Clinical stage, VH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors" Blood 100:1177-1184 (2002) co-authored with DG Oscier, AC Gardiner, SJ Mould,
S Glide, Z Davies, RE Ibbotson, MM Corcoran, RM Chapman, PW Thomas, JA Copplestone and JA Orchard
183. "Typical Waldenstrom's macroglobulinemia is derived from B-cells arrested following cessation of somatic mutation but prior to isotype switch events" Blood 100:1505-1507 (2002) co-authored with SS Sahota, F Foroni, CH Ottensmeier, D Provan, DG
Oscier and FK Stevenson
184. "B-cell receptor signaling responsiveness correlates with VH gene mutational status on chronic lymphocytic leukemia" Blood 101:1087-1093 (2003) co-authored with S Lanham, DG Oscier, FK Stevenson and G Packham
185. "The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis" Blood 100:3068-3076 (2002) co-authored with MS Cragg, HTC Chan, MD Fox, A Tutt, A Smith, DG Oscier and MJ Glennie
186. "ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome and distinct gene expression profile" Blood (2003) co-authored with Adrian Wiestner, Andreas Rosenwald, Todd
Barry, George Wright, R Eric Davis, Sarah E Henrickson, Hong Zhao, Rachel E Ibbotson, Jenny A Orchard, Zadie Davis, Maryalice Stetler-Stevenson, Mark Raffeld, Gerald E Marti, Wyndham H Wilson, David G Oscier and Louis M. Staudt
187. "DNA vaccines: stategies and ongoing trials" Haematologica 87 (2002) co-authored with FK Stevenson, C. Ottensmeier, H McCarthy, G Di Genova, N Savelyeva, SM Thirdborough, D Zhu and J Rice
188. "ZAP-70 expression by flow cytometry is a good prognostic marker in CLL and a potential surrogate for immunoglobulin VH gene mutations" Lancet co-authored with Jenny A Orchard, Rachel E Ibbotson, Zadie Davis, Adrian Wiestner, Andreas Rosenwald, Peter W Thomas, Louis M Staudt and David G Oscier
189. "Assessment of the immune capacity of myeloma patients post autologous transplantation provides information on timing of vaccine-based immunotherapy" Blood co-authored with FP McNicholl, HM McCarthy, J Roddick, G DiGenova, CH
Ottensmeier, KH Orchard, AS Dunscombe, AG Smith and FK Stevenson
190. "Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection" co-
authored with CI Mockridge, A Rahman, S Buchan, DA Isenberg, FK Stevenson and KN Potter
191. "AP3 is required for polarization and secretion at the immunological synapse in cytotoxic T lymphocytes" Immunity co-authored
with R Clark, J Stinhcombe, A Day, S Booth, G Davies and GM Griffiths
192. "Cost-utility of Rituximab (Mab Thera) in Diffuse Large B-cell Lymphoma" B J Haematol co-authored with J Hornebrger and S
Proctor
347. "Leucocyte alloantigens in the kidney: some anomalies" European Journal of Clinical Investigation 1: 56-57 (1971) co-authored
with J Verrier Jones and Barbara Moore
348. "The therapeutic use of plasmapheresis in an immune complex disease" Journal of Clinical Pathology 29:83 (1976) co-authored
with J Verrier Jones
349. "Trial of plasmapheresis in Crohn's disease" Gut :974-975 (1978) co-authored with G Holdstock, A Fisher and CA Loehry
350. "Correlation between immunological characteristics and clinical features of B cell chronic lymphocytic leukaemia" XVII
Congress of the International Society of Haematology, Paris, p.913 (1978) co-authored with D Hough
351. "The production of extracellular IgM by guinea pig and human leukaemia B lymphocytes" Fourth International Congress of
Immunology, Paris 6: 1-17 (1980) co-authored with FK Stevenson, S Hall and GT Stevenson
352. "Treatment of B cell lymphomas by anti-idiotype antibodies" Fourth International Congress of Immunology, Paris 10: 5-29
(1980) co-authored with GT Stevenson
353. "Plasma exchange of Crohns's disease" Nieren und Hochkrank 9: 43 (1980) co-authored with G Holdstock, A Fisher and CA
Loehry
354. "Reduction of blocking factor to immunotherapy by plasma exchange" Nieren und Hochkrank 9: 43 (1980) co-authored with J
Gordon, FK Stevenson and GT Stevenson
355. "Passive immunotherapy of lymphatic leukaemia with anti-idiotypic antisera" International Haematology p.253. European and
African Division, VI Meeting, Athens (1981) co-authored with J Gordon, FK Stevenson and G Stevenson
356. "Idiotypic production by human neoplastic B lymphocytes: its use in monitoring chemotherapy and immunotherapy" Journal of
Cellular Biochemistry supplement 6 p.69 (1982) co-authored with FK Stevenson, AL Tutt and GT Stevenson
357. "Surface free mu and free gamma chains on lymphoma cells: an immunoglobulin related non-idiotypic, tumour specific antigent"
Experimental Haematology 11: suppl. 14-32 (1983) co-authored with J Gordon and GT Stevenson
358. "How chronic lymphocytic leukaemia cells escape from treatment with antibodies to cell surface idiotype" Br J Haematol 54:
178 (1983) co-authored with J Gordon, FK Stevenson and GT Stevenson
359. "Cell markers in a large single centre series of chronic lymphocytic leukaemia: the relationship between CLL and ALL" Br J
Haematol 61: 556 (1985) co-authored with DG Oscier, EO Gregg and JL Smith
360. "Coexistent myelodysplasia in lymphoproliferative disorders" Br J Haematol 61: 557 (1985) co-authored with JA Copplestone,
GJ Mufti and DG Oscier
361. "Synergistic interactions of differentiation inducers and DNA synthesis inhibitors: in vitro studies and clinical trials in myelody-
splasia and refractory AML" Br J Haematol 81: 570 (1985) co-authored with GE Francis, GJ Mufti and JET Guimaraes
362. "Cytogenetic analysis of 113 patients with myelodysplastic syndrome" Br J Haematol 61: 571 (1985) co-authored with M
Fitchett, MJ Griffiths, GJ Mufti, DG Oscier and M Seabright
363. "Low dose Cytarabine (AraC) in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia" Br J
Haematol 61: 571 (1985)
364. "Chromosomal analyses in 52 cases of B CLL" Br J Haematol 61: 573 (1985) co-authored with DG Oscier, GJ Mufti, M Fitchett
and M Seabright
365. "Reactivity of CAMPATH-1 with lymphomas and its suitability for purging bone marrow autografts" Br J Haematol 64: 832 (1986)
co-authored with AJ Bell, JL Smith and DG Oscier
366. "Treatment of non-hodgkin's lymphoma with univalent monoclonal antibodies" Br J Haematol 64: 820 (1986) co-authored with
A Worsley, M Glennie, GJ Mufti, JE Smith, FK Stevenson and GT Stevenson
367. "The Kidney in Myeloma" Extracta Medica Acron Verlag 67 JB (1986)
368. "Monoclonal anti-light chain idiotype as a tumour specific probe for human cell lymphoma" Br J Cancer 55: 344 (1987) co-
authored with M Wrightham, AL Tutt, MJ Glennie, FK Stevenson and GT Stevenson
369. "CD3 CD8 positive lymphocytosis preceding the onset of B cell chronic lymphocytic leukaemia" Brit Soc Haem Lancaster
(1987) co-authored with JL Smith, DG Haegart, DB Jones, DH Wright, DG Oscier and N O'Connor
370. "Erythroid and granulocyte macrophage colony formation in myelodysplastic syndrome - colony numbers deteriorate with
worsening FAB category and Bournemouth score, but are not helpful in confirming early myelodysplastic changes in the
bone marrow" Br Soc Haem Lancaster (1987) co-authored with A Worsley, GJ Mufti, J Stevens, S Darlow, A Figes and DG
Oscier
371. "Prognostic features of chronic myelomonocytic leukaemia - a modified Bournemouth score gives the best prediction of survival"
Br Soc Haem Lancaster (1987) co-authored with A Worsley, JG Mufti, J Stevens, S Darlow, A Figes and DG Oscier
372. "Circulating stem cells accelerate haemopoietic reconstitution following autologous bone marrow transplantation" Br Soc Haem
Lancaster (1987) co-authored with AJ Bell, M Chisolm and DG Oscier
373. "Effector cell mechanisms operating against human B cell lymphoma: their possible involvement in maintaining long-term re-
mission and in immunotherapy with monoclonal anti-idiotype" Br J Haematol 68: 505 (1988) co-authored with FK Stevenson,
MH Wrightham, R Dearman and GT Stevenson
374. "Peripheral blood stem cell autografting in patients with lymphoid malignancies" Br J Haematol 66: 408 (1987) co-authored with
AJ Bell, A Figes and DG Oscier
375. "Treatment of chronic myelomonocytic leukaemia with low dose etoposide" Blut 56: C16 (1988) co-authored with DG Oscier, A
Worsley and JA Copplestone
376. "Circulating stem cell autografts in myeloma" Br J Haematol 70: 171 (1989) co-authored with PJ Williamson, AJ Bell, J North,
EJ Watts, RD Hyde, FK Stevenson and DG Oscier
377. "Chimaeric and bispecific monoclonal antibodies recruit IL-2 stimulated effector cells to participate in antibody dependent
cellular cytotoxicity" Br J Haematol 71: 5 suppl.1 (1989) co-authored with M Glennie, FK Stevenson and GT Stevenson
378. "Prognostic factors in stage AO B-cell chronic lymphocytic leukaemia" Br J Haematol 71: 23 Suppl.1 (1989) co-authored with
DG Oscier, J Stevens and M Fitchett
379. "CFU-GM dose effect in circulating stem cell autografts" Br J Haematol 71: 44 suppl.1 (1989) co-authored with AJ Bell, PJ
Williamson, S Thorogood and DG Oscier
380. "Side effects of treatment with Interleukin-2" Natural Immunity and Cell Growth Regulation 9:65 (1990)
381. "Management of chronic lymphoprolferative disorders" Bulletin of Royal College of Pathologists 72:v-vi (1990)
382. "A phase II study of human rIL-2 and 5-FU chemotherapy in the treatment of metastatic colorectal cancer" Proc ASCO 43:112
(1990) co-authored with PJ Williamson, DK George, R Oskam, PA Palmer and CR Franks
383. "Normal B cells bearing a cold agglutinin associated idiotype" 5th International Workshop on CLL, Sitges, 25 (1991) co-
authored with V Pascual, MB Spellerberg, JD Capra and FK Stevenson
384. "CLL trials in the UK. MRC trials 1, 2 and 3" 5th International Workshop on CLL, Sitges, 60 (1991) co-authored with D
Catovsky, S Richards, J Fooks and A Gates
385. "Response to Fludarabine after failure to respond to Epirubicin in Chlorambucil resistant, stage C, B-cell CLL" 5th International
Workshop on CLL, Sitges, 74 (1991) co-authored with J Orchard, S Sadullah and D Oscier
386. "Establishing the incidence of MDS - population surveys" Leuk Res 15 (Suppl): 4 (1991) co-authored with PJ Williamson, DG
Oscier and AR Kruger
387. "Has survival improved in the past ten years?" Leuk Res 15 (Suppl): 11 (1991) co-authored with P Reynolds, A Kruger, S
Sadullah and D Oscier
388. "The past, the present and the future" Leuk Res 15 (Suppl): 14 (1991)
389. "A phase II study of the treatment of metastatic malignant melanoma with the combination of Dacarbazine, Cis-platin, interleukin-2, and alfa-interferon" Proc ASCO 10: 294 (1991) co-authored with B Davies, S Sadullah, Roskam, P Palmer and
CR Franks
390. "Structural basis for a cross reacting idiotype characteristic of human cold agglutinins of anti-li specificity" Blood 78: suppl 1, 441a (1991) co-authored with FK Stevenson, MB Spellerberg, LC Jefferies, J Goldman, V Pascual, JD Capra and LE
Silberstein
391. "Auto red cell antibodies synthesised by patients with infectious mononucleosis utilize the VH 4-21 gene segment" Blood 80
Suppl 1:201 (1992) co-authored with CJ Chapman, MB Spellerberg, GA Smith, SJ Carter and FK Stevenson
392. "Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome" Blood 80 Suppl 1:1882 (1992) co-authored
with DG Oscier, A Kruger, S Sadullah, R Chapman and E Hodges
393. "Anti-red cell antibodies synthesised by patients with infectious mononucleosis utilise the VH 4-21 gene segment" Brit J
Haematol 84 (Suppl 1) 9 (1993) co-authored with CJ Chapman, MB Spellerberg, GA Smith, SJ Carter, FK Stevenson
394. "A comparison of bispecific antibody/saporin complexes and chimaeric mouse fab/human bis-Fc antibodies in the treatment of
low grade lymphoma" Brit J Haematol 84 (Suppl 1) 14 (1993) co-authored AJ Bell, G Mead, S Sadullah, RR French, MJ
Glennie, FK Stevenson and GT Stevenson
395. "The effect of karyotypic analysis on the Bournemouth score in primary myelodysplastic syndrome (MDS): Reappraisal of the
Bournemouth experience" Brit J Haematol 84 (Suppl 1) 18 (1993) co-authored with AR Kruger, PJ Reynolds, S Sadullah and
DG Oscier
396. "Establishing the incidence of myelodysplastic syndrome" Brit J Haematol 84 (Suppl 1) 33 (1993) co-authored with PJ
Williamson, DG Oscier, AR Kruger and PJ Reynolds
397. "Survival prospects have not improved for the myelodysplastic syndrome in the past ten years" Brit J Haematol 84 (Suppl 1) 34
(1993) co-authored with AR Kruger, PJ Reynolds, S Sadullah and DG Oscier
398. "Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome" Brit J Haematol 84 (Suppl 1) 42 (1993) co-
authored with A Kruger, S Sadullah, B Chapman, E Hodges, S Mould and DG Oscier
399. "Differential usage of an immunoglobulin heavy chain variable region gene by B cell tumours" Brit J Haematol 84 (Suppl 1) 42
(1993)
400. "A Case of blastic transormation of chronic granulocytic leukaemia showing pericentric inversion of chromosome 16 without the
M4 Eo phenotype" Brit J Haematol 84 (Suppl 1) 50 (1993) co-authored with H Myint, FM Ross and JL Hall
401. "Fatal microvascular infarction of the brain in a patient with mild sickle cell disease" Brit J Haematol 84 (Suppl 1) 65 (1993) co-
authored with H Myint, DG Oscier, S Sadullah and M Lesna
402. "Treatment of B-cell lymphoma with a combination of bispecific antibodies and saporin" Br J Haematol 86: (Suppl 1) 24 (1994)
co-authored with RR French, A Bell, AL Tutt and MJ Glennie
403. "Assessment of the role of clonogenic lymphocytes in the pathogenesis of multiple myeloma" Brit J Haematol 86: (Suppl 1) 31
(1994) co-authored with S Sahota, DG Oscier and FK Stevenson
404. "Chronic lymphocytic leukaemia expressing surface surface lgG preferentially uses the VH4-21 gene in mutated form" Brit J
Haematol 86: (Suppl 1) 41 (1994) co-authored with MB Spellerberg, CJ Chapman, D Samson and FK Stevenson
405. "Plasmid vaccination to elicit anti-idiotypic responses against surface immunoglobulin positive B-cell malignancies" Brit J
Haematol 86: (Suppl 1) 74 (1994) co-authored with SJ Russel, G Winter, FK Stevenson and RE Hawkins
406. "Use of a phage expression system to produce Fabs from human autoanti-DNA antibodies encoded by the VH4-21 gene seg-
ment" Brit Soc Immunol Spring Meeting 4: 1.5. (1994) co-authored with CJ Chapman, CI Mockeridge, M Ehrenstein, DA
Isenberg and FK Stevenson
407. "Use of VH gene sequence analysis to assess the nature of the clonagenic cell in human multiple myeloma" Brit Soc Immunol
Spring Meeting 8:2.5 (1994) co-authored with S Sahota, DG Oscier and FK Stevenson
408. "Pathway of presentation of endogenous idiotypic IgM by B cells to specific T cell hybridomas" Immunol Spring Meeting 11:3.1
(1994) co-authored with CA King, MR Wills and FK Stevenson
409. "Clinical toxicity of cytokines" Human and Experimental Toxicology 13: 613 (1994)
410. "Comparison of scoring systems for prognosis in MDS" Leuk Res 18 Suppl: 40 (1994) co-authored with A Kruger, J Freeman,
R Chapman and D Oscier
411. "Atypical lymphocyte morphology and abnormal karyotype predict disease progression in stage A and AO chronic lymphocytic
leukemia" Blood 84:452a (1994) co-authored with D Oscier, A Copplestone, R Chapman, R Gillingham, D Catovsky and E
Matutes
412. "Trisomy 12 defines a subgroup of CLL with a distinct morphology" Blood 84:656a (1994) co-authored with E Matutes, D
Oscier, J Garcia-Marco, J Ellis, R Chapman, R Gillingham and D Catovsky
413. "Idiotypic plasmid vaccination for follicular B-cell lymphoma" Path Biol 42:1068 (1994) co-authored with SJ Russell, G Winter,
FK Stevenson and RE Hawkins
414. "Trisomy 12 defines a group of CLL with atypical morphology. Correlation between cytogenetics, clinical and laboratory features
in 544 patients" Brit J Haem 89:51 (1995) co-authored with E Matutes, D Oscier, J Garcia-Marco, J Ellis, R Chapman, R
Gillingham, D Lens and D Catovsky
415. "Fludarabine related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia" Brit J Haem 89:81
(1995) co-authored with H Myint, JA Copplestone, J Orchard, V Craig, D Curtis, MD Hamon, AG Prentice and DG Oscier
416. "Immunoglobulin variable region genes as DNA vaccines for myeloma" Vth International Workshop on Multiple Myeloma La
Baule, France. p 3.132 (1995) co-authored with FK Stevenson, D Zhu, RE Hawkins, LJ Ashworth, S Sahota, CA King and
DG Oscier
417. "Immunoglobulin VH gene mutational patterns indicate different tumor cell status in human myeloma and MGUS" Vth Inter-
national Workshop on Multiple Myeloma La Baule, France. p 318 (1995) co-authored with S Sahota, R Leo and FK
Stevenson
418. "International worksho consensus risk analysis system for myelodysplastic syndromes (MDS)" Blood 86: 270a (1995) co-
authored with P Greenberg, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, D Oscier, K Ohyashki, K Toyama, C Aul, G
Mufti, J Bennett, C Cox and M LeBeau
419. "DNA vaccines against B cell tumours" Immunology 86 (suppl 1): 7 (1995) co-authored with FK Stevenson, D Zhu, RE Hawkins,
LJ Ashworth, A Thompsett, CA King, MB Spellerberg, S Kumar
420. "Efficacy and cost effectiveness of Tazocin and Gentamicin in neutropenic fever in patients with haemato-oncological malignancies" Int J Haematol 64: suppl 1, S116 (1995) co-authored with H Myint, H Grech, S Bolam, R Hall, D McCormack, S Hazal, M Feeney, AA Kyi, E Burton-Thorne and DG Oscier
421. "Effectiveness if amphoteracin B lipid complex (ABLC) in neutropenic patients with radiological evidence of pulmonary fungal infections" Int J Haematol suppl 1, S123 (1996) co-authored with H Myint, S Bolam, J Orchard, AA Kyi and DG Oscier
422. "Recent developments in the prognostic classification for MDS: Results of the international risk analysis workshop" Leuk Res 21 (Suppl 1) S13 (1997) co-authored with P Greenberg, C Cox, M Le Beau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, D Oscier, K Ohyashiki, K Toyama, C Aul, G Mufti and J Bennett
423. "Immunology of MDS. Towards a DNA vaccine" Leuk Res 21(suppl 1): S19 (1997) co-authored with J Rice, DG Oscier and FK Stevenson
424. "DNA vaccines against the idiotypic immunoglobulin of B cell tumours" J Mol Med 75: B163 (1997) co-authored with D Zhu, CA King, A Thomsett, J Rice, S Sahota and FK Stevenson
425. "Autoimmune haemolytic anaemia in patients treated with purine analogues" Hematology and Cell Therapy 39 (Suppl 1): S59 (1997)
426. "Trigger factors for platelet factors in the elderly" RCPE/Consensus Conference on Platelet Transfusion p4 (November, 1997) co-authored with R Hall
427. "In patients with lymphoma recovering from autoimmune complications of fludarabine, relapse may be triggered by conventional chemotherapy" Brit J Haematol 101 (Suppl 1): 43 (1998) co-authored with J Orchard, S Bolam, H Myint and DG Oscier
428. "The use of immunoglobulin heavy chain variable region genes in chronic lymphocytic leukaemia" Brit J Haematol 101 (suppl 1): 44 (1998) co-authored with Z Davis, DG Oscier and FK Stevenson
429. "Preliminary results of the UK medical research Council trial in chronic lymphocytic leukaemia - CLL3" Brit J Haematol 102:278 (1998) co-authored with D Catovsky and S Richards
430. "The use of immunoglobulin heavy chain genes in chronic lymphocytic leukemia" The Cancer Journal (1998) co-authored with Z Davis, DG Oscier and FK Stevenson
431. "In chronic lymphocytic leukemias germline configuration of immunoglobulin heavy chain genes is associated with a more aggressive form of the disease" Blood 92 (Suppl 1): 515a (1998)
432. "Autoimmune thrombocytopenia (ITP) in low grade lymphoproliferative disorders treated with fludarabine (FDR)" Blood 92 (Suppl 1): 82b (1998) co-authored with S Bolam, J Orchard, D Oscier, H Myint and R Hall
433. "In chronic lymphocytic leukaemia (CLL) autoimmune haemolytic anaemia (AIHA) is not related to any particular immuno-globulin V gene usage" Brit J Haematol 105 (suppl 1): 88 (1999) co-authored with Z Davies, D Oscier and F Stevenson
434. "Autoimmune thrombocytopenia (ITP) following fludarabine therapy in low grade lymphoproliferative disorders" Brit J Haematol 105 (suppl 1): 88 (1999) co-authored with R Hall, S Bolam, J Orchard, D Oscier and H Myint
435. "Immunoglobulin VH gene analysis suggests that chronic lymphocytic leukaemia (CLL) may derive from either naive or memory B cells. Tumours of naive B cells have a much worse prognosis" Brit J Haematol 105 (suppl 1): 103 (1999) co-authored with Z Davis, D Oscier and F Stevenson
436. "immunoglobulin VH gene analysis suggests that CLL may derive from either naive or memory B cells; tumours of naive B cells have a much worse prognosis" VIII International Workshop on CLL abstracts 33 (October 29-31, 1999) co-authored with Z Davies, A Gardiner, D Oscier and F Stevenson
437. "In CLL, autoimmune haemolytic anaemia is not related to any particular immunoglobulin gene usage" VIII International Work-shop on CLL abstracts 33 (October 29-31, 1999) co-authored with Z Davis, D Oscier, and F Stevenson
438. "Autoimmune phenomena following treatment with fludarabine" VIII International Workshop on CLL abstracts 58 (October 29-31, 1999) co-authored with R Hall, S Bolam, J Orchard, D Oscier, and H. Myint
439. "Vaccine development in CLL - lessons from lymphoma" VIII International Workshop on CLL abstracts 24 (October 29-31, 1999) co-authored with FK Stevenson, D Zhu, MB Spellerberg, SS Sahota, CA King and J Rice
440. "Discordant somatic mutation of immunoglobulin variable region genes and BCL-6 genes in chronic lymphocytic leukaemia" Blood Suppl 1 662a abstract 2939 (1999) co-authored with SS Sahota, Z Davis and FK Stevenson
441. "In chronic lymphocytic leukaemia surface CD38 positivity is an independent poor prognostic factor. It does not correlate with v gene mutational status" Brit J Haem 108 Suppl 1: 28 (2000) co-authored with Jennifer Orchard, Zadie Davis, Ann Gardiner, David G Oscier and Freda K Stevenson
442. "Discordant somatic mutation of immunoglobulin variable region genes and bcl-6 genes in chronic lymphocytic leukemia" Brit J Haem 108 Suppl 1: 51 (2000) co-authored with Surinder S Sahota, Zadie Davis and Freda K Stevenson
443. "The mutational status of immunoglobulin V genes is the most important prognostic factor in B-CLL" Blood 96: 366a (2000) co-authored with David G Oscier, A Gardiner, S Mould, S Glide, Z Davis, MA Corcoran, R Ibbotson, J Orchard, JA Copplestone and FK Stevenson
444. "UK Medical research council CLL3 - a randomised trial of the addition of epirubicin to standard chlorambucil treatment" Blood 96:754a (2000) co-authored with D Catovsky and S Richards
445. "Can CD38 expression act as a surrogate marker for Ig V gene mutational status in B-CLL" Blood 96: 835a (2000) co-authored with DG Oscier, JA Orchard, R Ibbotson, Z Davis and FK Stevenson
446. "Typical Waldenstrom's macroglobulinemia and IgM secreting MGUS are each derived from B-cells arrested following cessation of somatic mutation but prior to isotype switch events" Blood 98: 154a (2001) co-authored with SS Sahota, F Foroni, CH
Ottensmeier, D Provan, DG Oscier and FK Stevenson
447. "Immunoglobulin genes and CLL subsets" Leukemia & Lymphoma 42:suppl 1:9-10 (2002) co-authored with JA Orchard, RE Ibbotson, Z Davis, PW Thomas, FK Stevenson and DG Oscier
448. "DNA vaccination to activate immune attack on CLL" Leukemia & Lymphoma 42:suppl 1:15-16 (2002) co-authored with FK Stevenson, J Rice, H McCarthy and N Savelyeva
449. "Sex as a prognostic factor in CLL. An analysis from MRC trials" Leukemia & Lymphoma 42:suppl 1:50-51 (2002) co-authored with D Catovsky, J Halsey, S Richards, DW Milligan, AJ Child, AG Smith and SA Schey
450. "Cost-effectiveness of Rituximab in treatment of diffuse large B-cell lymphoma in the UK" Br J Haematol 117 suppl 1:59-60 (2002) co-authored with JH Best, J Morris and J Hornberger
451. "Zap-70 evaluation by flow cytometry is a significant prognostic marker in B-CLL" Blood 100:168a (2002) co-authored with JA Orchard, RE Ibbotson, ZA Davis, AC Gardiner and DG Oscier
452. "Zap-70 expression identifies B-CLL with unmutated immunoglobulin genes, worse clinical outcome and a distinct gene expression profile" Blood 100:168a (2002) co-authored with A Weistner, A Rosenwald, T Barry, RE Ibbotson, M Stetler-Stevenson, JA Orchard, WH Wilson, DG Oscier and LM Staudt
453. "VH gene mutational status in chronic lymphocytic leukemia is associated with differential signalling via IgM" Blood 100: 99a (2002) co-authored with FK Stevenson, S Lanham, DG Oscier and G Packham
454. "Heterogeneity of expression of Toll-like receptor RP105 (CD180) by B-cell chronic lymphocytic leukaemic (B-CLL) cells" Blood 100:353b (2002) co-authored with N Porakishvili, N Kulikova, S Sundar, AP Jewell, PY Youinou, S Nedelec, K Yong, F
Stevenson, P Wallace, P Ely, EA Clark and PM Lydyard
455. "Failure to provide irradiated blood components is significantly under-reported" Brit J Haematol 121: Suppl 1, 78 (2003) co-authored with EJ Massey, JA James, H Sethi, JA Copplestone, S O'Reilly, R Noble, RJ Lusj, S Chown, S Bolam, S Smith, B Attock, J Cullis, R Lee, F Jack and S Caldwell

347. "Leucocyte alloantigens in the kidney: some anomalies" European Journal of Clinical Investigation 1: 56-57 (1971) co-authored
with J Verrier Jones and Barbara Moore
348. "The therapeutic use of plasmapheresis in an immune complex disease" Journal of Clinical Pathology 29:83 (1976) co-authored
with J Verrier Jones
349. "Trial of plasmapheresis in Crohn's disease" Gut :974-975 (1978) co-authored with G Holdstock, A Fisher and CA Loehry
350. "Correlation between immunological characteristics and clinical features of B cell chronic lymphocytic leukaemia" XVII
Congress of the International Society of Haematology, Paris, p.913 (1978) co-authored with D Hough
351. "The production of extracellular IgM by guinea pig and human leukaemia B lymphocytes" Fourth International Congress of
Immunology, Paris 6: 1-17 (1980) co-authored with FK Stevenson, S Hall and GT Stevenson
352. "Treatment of B cell lymphomas by anti-idiotype antibodies" Fourth International Congress of Immunology, Paris 10: 5-29
(1980) co-authored with GT Stevenson
353. "Plasma exchange of Crohns's disease" Nieren und Hochkrank 9: 43 (1980) co-authored with G Holdstock, A Fisher and CA
Loehry
354. "Reduction of blocking factor to immunotherapy by plasma exchange" Nieren und Hochkrank 9: 43 (1980) co-authored with J
Gordon, FK Stevenson and GT Stevenson
355. "Passive immunotherapy of lymphatic leukaemia with anti-idiotypic antisera" International Haematology p.253. European and
African Division, VI Meeting, Athens (1981) co-authored with J Gordon, FK Stevenson and G Stevenson
356. "Idiotypic production by human neoplastic B lymphocytes: its use in monitoring chemotherapy and immunotherapy" Journal of
Cellular Biochemistry supplement 6 p.69 (1982) co-authored with FK Stevenson, AL Tutt and GT Stevenson
357. "Surface free mu and free gamma chains on lymphoma cells: an immunoglobulin related non-idiotypic, tumour specific antigent"
Experimental Haematology 11: suppl. 14-32 (1983) co-authored with J Gordon and GT Stevenson
358. "How chronic lymphocytic leukaemia cells escape from treatment with antibodies to cell surface idiotype" Br J Haematol 54:
178 (1983) co-authored with J Gordon, FK Stevenson and GT Stevenson
359. "Cell markers in a large single centre series of chronic lymphocytic leukaemia: the relationship between CLL and ALL" Br J
Haematol 61: 556 (1985) co-authored with DG Oscier, EO Gregg and JL Smith
360. "Coexistent myelodysplasia in lymphoproliferative disorders" Br J Haematol 61: 557 (1985) co-authored with JA Copplestone,
GJ Mufti and DG Oscier
361. "Synergistic interactions of differentiation inducers and DNA synthesis inhibitors: in vitro studies and clinical trials in myelody-
splasia and refractory AML" Br J Haematol 81: 570 (1985) co-authored with GE Francis, GJ Mufti and JET Guimaraes
362. "Cytogenetic analysis of 113 patients with myelodysplastic syndrome" Br J Haematol 61: 571 (1985) co-authored with M
Fitchett, MJ Griffiths, GJ Mufti, DG Oscier and M Seabright
363. "Low dose Cytarabine (AraC) in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia" Br J
Haematol 61: 571 (1985)
364. "Chromosomal analyses in 52 cases of B CLL" Br J Haematol 61: 573 (1985) co-authored with DG Oscier, GJ Mufti, M Fitchett
and M Seabright
365. "Reactivity of CAMPATH-1 with lymphomas and its suitability for purging bone marrow autografts" Br J Haematol 64: 832 (1986)
co-authored with AJ Bell, JL Smith and DG Oscier
366. "Treatment of non-hodgkin's lymphoma with univalent monoclonal antibodies" Br J Haematol 64: 820 (1986) co-authored with
A Worsley, M Glennie, GJ Mufti, JE Smith, FK Stevenson and GT Stevenson
367. "The Kidney in Myeloma" Extracta Medica Acron Verlag 67 JB (1986)
368. "Monoclonal anti-light chain idiotype as a tumour specific probe for human cell lymphoma" Br J Cancer 55: 344 (1987) co-
authored with M Wrightham, AL Tutt, MJ Glennie, FK Stevenson and GT Stevenson
369. "CD3 CD8 positive lymphocytosis preceding the onset of B cell chronic lymphocytic leukaemia" Brit Soc Haem Lancaster
(1987) co-authored with JL Smith, DG Haegart, DB Jones, DH Wright, DG Oscier and N O'Connor
370. "Erythroid and granulocyte macrophage colony formation in myelodysplastic syndrome - colony numbers deteriorate with
worsening FAB category and Bournemouth score, but are not helpful in confirming early myelodysplastic changes in the
bone marrow" Br Soc Haem Lancaster (1987) co-authored with A Worsley, GJ Mufti, J Stevens, S Darlow, A Figes and DG
Oscier
371. "Prognostic features of chronic myelomonocytic leukaemia - a modified Bournemouth score gives the best prediction of survival"
Br Soc Haem Lancaster (1987) co-authored with A Worsley, JG Mufti, J Stevens,

[juliod]

Here is a list of some of the published scientific papers produced by todays creationary scientists

Oh, boy! Another list-poster.

Since you are obviosuly familiar with this list, can you point out a few of the papers that are actually creationist? Are any of them actually relevant to creation?

What you have posted is a list of papers that someone claims one or more of the authors are creationists. That implies nothing about whether the papers are examples of creationism, or whether they contributed anything.

DanZ